← The Wire
ANIXNasdaq
Anixa Biosciences Inc
Pharmaceutical Preparations · DE · CIK 715446
Anixa Biosciences develops cancer therapies and vaccines, including a CAR-T therapy for ovarian cancer
$84M
Market cap
$2.85
Last close
+2.1%
1D
+2.9%
5D
429K
Volume
Price · last 39 sessions-6.9%
May 4L $2.35 · H $3.06Jun 29
320
Total filings
Jun 10, 2026
Last filing
10/31
Fiscal year end
10-Q10-QJun 10, 20268-KShareholder Vote · Reg FD DisclosureMar 11, 202610-Q10-QMar 9, 20268-KReg FD DisclosureFeb 9, 2026DEF 14ADEF 14AJan 28, 202610-K10-KJan 12, 2026SC 13D/ASC 13D/AJan 6, 20268-KReg FD DisclosureDec 12, 202510-Q10-QSep 10, 202510-Q10-QMay 28, 20258-KShareholder Vote · Reg FD DisclosureMar 21, 202510-Q10-QMar 11, 2025DEF 14ADEF 14AFeb 6, 202510-K10-KJan 10, 20258-KReg FD DisclosureNov 8, 202410-Q10-QSep 6, 202410-Q10-QJun 4, 20248-KMaterial Agreement · Reg FD DisclosureMay 8, 2024SC 13DSC 13DMay 3, 20248-KShareholder Vote · Reg FD DisclosureMar 22, 202410-Q10-QMar 12, 2024DEF 14ADEF 14AFeb 8, 202410-K10-KJan 16, 20248-KReg FD DisclosureDec 7, 202310-Q10-QSep 6, 202310-Q10-QJun 14, 20238-KReg FD DisclosureApr 17, 202310-Q10-QMar 17, 20238-KShareholder Vote · Reg FD DisclosureMar 10, 2023DEF 14ADEF 14AJan 27, 202310-K10-KJan 4, 20238-KReg FD DisclosureDec 8, 20228-KReg FD DisclosureSep 29, 202210-Q10-QSep 9, 20228-KCompany UpdateAug 17, 202210-Q10-QJun 10, 20228-KExecutive ChangeApr 15, 20228-KShareholder Vote · Reg FD DisclosureMar 11, 202210-Q10-QMar 11, 2022DEF 14ADEF 14AJan 28, 202210-K10-KJan 4, 20228-KCompany UpdateDec 9, 20218-KReg FD DisclosureOct 28, 20218-KCompany UpdateOct 4, 202110-Q10-QSep 1, 20218-KAgreement TerminatedJun 16, 202110-Q10-QJun 10, 20218-KShareholder Vote · Reg FD DisclosureMay 27, 2021DEF 14ADEF 14AApr 9, 20218-KExecutive Change · Bylaw AmendmentApr 2, 20218-KMaterial AgreementMar 24, 2021424B5424B5Mar 24, 2021424B5424B5Mar 22, 202110-Q10-QMar 11, 20218-KMaterial AgreementJan 28, 202110-K10-KJan 7, 20218-KMaterial AgreementDec 1, 20208-KReg FD DisclosureSep 16, 202010-Q10-QSep 8, 20208-KBylaw Amendment · Shareholder VoteAug 17, 2020DEFA14ADEFA 14AJul 20, 2020DEF 14ADEF 14AJul 2, 20208-KCompany UpdateJul 2, 202010-QFORM 10-QJun 9, 20208-KMaterial AgreementApr 20, 202010-QFORM 10-QMar 9, 202010-K/AFORM 10-K/AJan 10, 202010-KFORM 10-KJan 9, 20208-KShareholder Vote · Reg FD DisclosureOct 24, 2019DEF 14ADEF 14ASep 12, 201910-QFORM 10-QSep 6, 20198-KCompany UpdateAug 27, 20198-KReg FD DisclosureAug 21, 20198-KMaterial AgreementJul 18, 201910-QFORM 10-QJun 12, 20198-KReg FD DisclosureMay 23, 201910-QFORM 10-QMar 13, 20198-KCompany UpdateJan 25, 201910-KFORM 10-KJan 11, 20198-KBylaw Amendment · Shareholder VoteOct 1, 2018
Insider Activity
In the 90 days to Jan 28, 2026: 1 insider bought $30K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 28, 2026 | Baskies Arnold MDirector | Buy | 10,000 | $3.04 | $30K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance